Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors (Q39702119)

14 September 2017

Cancer-cell-specific induction of apoptosis using mesoporous silica nanoparticles as drug-delivery vectors (English)

1 reference

14 September 2017

0 references

0 references

1 reference

1

1 reference

14 September 2017

Emilia Peuhu

2

0 references

Cecilia Sahlgren

series ordinal

5

object named as

Cecilia Sahlgren

1 reference

14 September 2017

Laurel Tabe Bate-Eya

3

1 reference

PubMed ID

20486218

14 September 2017

John E Eriksson

series ordinal

4

1 reference

PubMed ID

20486218

14 September 2017

Mika Lindén

series ordinal

6

1 reference

14 September 2017

1 June 2010

1 reference

14 September 2017

1 reference

14 September 2017

6

1 reference

14 September 2017

11

1 reference

14 September 2017

1234-1241

1 reference

Nanoparticle therapeutics: an emerging treatment modality for cancer

14 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Mesoporous silica nanoparticles as controlled release drug delivery and gene transfection carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Recent development, applications, and perspectives of mesoporous silica particles in medicine and biotechnology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Mesoporous silica nanoparticles as a delivery system for hydrophobic anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Targeting of porous hybrid silica nanoparticles to cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Mannose-targeted mesoporous silica nanoparticles for photodynamic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Targeted drug delivery via the folate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Folate-mediated targeting: from diagnostics to drug and gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Folate-targeted chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Cell-induced intracellular controlled release of membrane impermeable cysteine from a mesoporous silica nanoparticle-based drug delivery system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Anticancer Antifolates: Current Status and Future Directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Liposomes containing alkylated methotrexate analogues for phospholipase A(2) mediated tumor targeted drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Methotrexate conjugated to gold nanoparticles inhibits tumor growth in a syngeneic lung tumor model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Methotrexate-immobilized poly(ethylene glycol) magnetic nanoparticles for MR imaging and drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Tumor-targeted drug delivery and MRI contrast enhancement by chlorotoxin-conjugated iron oxide nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Biofunctionalized, phosphonate-grafted, ultrasmall iron oxide nanoparticles for combined targeted cancer therapy and multimodal imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Polymer-modified gadolinium metal-organic framework nanoparticles used as multifunctional nanomedicines for the targeted imaging and treatment of cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Methotrexate-loaded biodegradable polymeric micelles: preparation, physicochemical properties and in vitro drug release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Cellular uptake mechanism of an inorganic nanovehicle and its drug conjugates: Enhanced efficacy due to clathrin-mediated endocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Syntheses of alpha- and gamma-substituted amides, peptides, and esters of methotrexate and their evaluation as inhibitors of folate metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Methotrexate analogues. 28. Synthesis and biological evaluation of new gamma-monoamides of aminopterin and methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Silica-based mesoporous materials as drug delivery system for methotrexate release

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Sheddable coatings for long-circulating nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Cancer-cell targeting and cell-specific delivery by mesoporous silica nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Methotrexate loaded self stabilized calcium phosphate nanoparticles: a novel inorganic carrier for intracellular drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

Targeted Intracellular Delivery of Hydrophobic Agents using Mesoporous Hybrid Silica Nanoparticles as Carrier Systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSMLL.200902355

21 January 2018

Identifiers

DOI

10.1002/SMLL.200902355

1 reference

14 September 2017

1 reference

PubMed ID

20486218